查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417566

Cystatin C測量市場報告：2030 年趨勢、預測與競爭分析

Cystatin C Assay Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

Cystatin C測量的趨勢與預測

預計到 2030 年，全球Cystatin C測量市場將達到約 5 億美元，2024 年至 2030 年複合年成長率為 7.6%。該市場的主要促進因素是腎臟疾病盛行率的增加和 POC 檢測的日益普及。全球Cystatin C測量市場的未來前景看好，酵素免疫分析法測定 (ELISA)、顆粒增強比濁免疫檢測(PETIA) 和顆粒增強比濁免疫檢測(PENIA) 市場充滿機會。

Cystatin C測量市場洞察

Lucintel 預測，由於臨床診斷和研究對高通量、高精度分析儀器的需求不斷增加，分析儀器預計將在預測期內實現最高成長。

由於酵素免疫分析法測定（ELISA）在腎功能監測和診斷方面的應用不斷擴大，它仍然是該市場最大的細分市場。

由於該地區慢性腎臟病的增加、人口老化以及醫療保健支出的增加，預計北美地區在預測期內將經歷最高的成長。

常問問題

Q1.市場規模有多大？

A1. 到 2030 年，全球Cystatin C測量市場預計將達到 5 億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球Cystatin C測量市場預計將以7.6%的複合年成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要驅動力是腎臟疾病盛行率的增加和 POC 檢測的日益普及。

Q4.市場的主要細分市場是什麼？

A4.Cystatin C測量市場的未來前景看好，酵素免疫分析法測定 (ELISA)、顆粒增強比濁免疫檢測(PETIA) 和顆粒增強比濁免疫檢測(PENIA) 市場都有機會。

Q5.市場上主要企業有哪些？

A5. 測量Cystatin C的主要企業如下。

  • Abbott
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Randox Laboratories

Q6.未來最大的細分市場是什麼？

A6.Lucintel預測，由於臨床診斷和研究對高通量、高精度分析儀器的需求不斷增加，分析儀器將在預測期內經歷最高成長。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 由於慢性腎臟病的增加、人口老化和醫療保健支出的增加，預計北美將在預測期內經歷最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 允許 10% 的客製化，無需額外費用。

目錄

第1章執行摘要

第2章全球Cystatin C測量市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球Cystatin C測量市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品分類的全球Cystatin C測量市場
    • 分析儀
    • 套件
    • 試劑
  • 按樣品類型分類的全球Cystatin C測量市場
    • 血
    • 尿
  • 按方法分類的全球Cystatin C測量市場
    • 酵素免疫分析法測定法 (ELISA)
    • 粒子增強免疫檢測(PETIA)
    • 粒子增強比濁免疫檢測(PENIA)
    • 其他
  • 全球Cystatin C測量市場（依應用）
    • 診斷
    • 調查

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球Cystatin C測量市場（按地區）
  • 北美胱Cystatin C測量市場
  • 歐洲Cystatin C測量市場
  • 亞太地區Cystatin C測量市場
  • 其他地區Cystatin C測量市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球Cystatin C測量市場成長機會（按產品）
    • 按樣本類型分類的全球Cystatin C測量市場成長機會
    • 全球Cystatin C測量市場成長機會（按方法）
    • 全球Cystatin C測量市場成長機會（按應用）
    • 全球Cystatin C測量市場按地區成長機會
  • 全球Cystatin C測量市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球Cystatin C測量市場的產能擴張
    • 全球Cystatin C測量市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Abbott
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Randox Laboratories
簡介目錄

Cystatin C Assay Trends and Forecast

The future of the global cystatin C assay market looks promising with opportunities in the enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), and particle-enhanced nephelometric immunoassay (PENIA) markets. The global cystatin c assay market is expected to reach an estimated $0.5 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of kidney diseases and growing adoption of POC testing.

A more than 150-page report is developed to help in your business decisions.

Cystatin C Assay by Segment

The study includes a forecast for the global cystatin c assay by product, sample type, method, application, and region.

Cystatin C Assay Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Analyzers
  • Kits
  • Reagents

Cystatin C Assay Market by Sample Type [Shipment Analysis by Value from 2018 to 2030]:

  • Blood
  • Urine

Cystatin C Assay Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  • Particle-Enhanced Nephelometric Immunoassay (PENIA)
  • Others

Cystatin C Assay Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostics
  • Research

Cystatin C Assay Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cystatin C Assay Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cystatin C assay companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cystatin C assay companies profiled in this report include-

  • Abbott
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Randox Laboratories

Cystatin C Assay Market Insights

Lucintel forecasts that analyzer is expected to witness the highest growth over the forecast period due to rising demand for high-throughput and accurate analyzers for clinical diagnosis and research.

Within this market, enzyme-linked immunosorbent assay (ELISA) will remain the largest segment due to its growing application in monitoring and diagnostic of kidney funtion.

North America is expected to witness highest growth over the forecast period due to rise in chronic kidney disease, growing aging population, and increasing healthcare expenditure in the region.

Features of the Global Cystatin C Assay Market

Market Size Estimates: Cystatin C assay market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cystatin C assay market size by various segments, such as by product, sample type, method, application, and region in terms of value ($B).

Regional Analysis: Cystatin C assay market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, sample types, methods, applications, and regions for the cystatin c assay market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cystatin C assay market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the cystatin C assay market size?

Answer: The global cystatin C assay market is expected to reach an estimated $0.5 billion by 2030.

Q2. What is the growth forecast for cystatin c assay market?

Answer: The global cystatin C assay market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the cystatin C assay market?

Answer: The major drivers for this market are increasing prevalence of kidney diseases and growing adoption of POC testing.

Q4. What are the major segments for cystatin C assay market?

Answer: The future of the cystatin c assay market looks promising with opportunities in the enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), and particle-enhanced nephelometric immunoassay (PENIA) markets.

Q5. Who are the key cystatin C assay market companies?

Answer: Some of the key cystatin C assay companies are as follows.

  • Abbott
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Randox Laboratories

Q6. Which cystatin C assay market segment will be the largest in future?

Answer: Lucintel forecasts that analyzer is expected to witness the highest growth over the forecast period due to rising demand for high-throughput and accurate analyzers for clinical diagnosis and research.

Q7. In cystatin C assay market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rise in chronic kidney disease, growing aging population, and increasing healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cystatin c assay market by product (analyzers, kits, and reagents), sample type (blood and urine), method (enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), particle-enhanced nephelometric immunoassay (PENIA), and others), application (diagnostics and research), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cystatin C Assay Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cystatin C Assay Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cystatin C Assay Market by Product
    • 3.3.1: Analyzers
    • 3.3.2: Kits
    • 3.3.3: Reagents
  • 3.4: Global Cystatin C Assay Market by Sample Type
    • 3.4.1: Blood
    • 3.4.2: Urine
  • 3.5: Global Cystatin C Assay Market by Method
    • 3.5.1: Enzyme-Linked Immunosorbent Assay (ELISA)
    • 3.5.2: Particle-Enhanced Turbidimetric Immunoassay (PETIA)
    • 3.5.3: Particle-enhanced Nephelometric Immunoassay (PENIA)
    • 3.5.4: Others
  • 3.6: Global Cystatin C Assay Market by Application
    • 3.6.1: Diagnostics
    • 3.6.2: Research

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cystatin C Assay Market by Region
  • 4.2: North American Cystatin C Assay Market
    • 4.2.2: North American Cystatin C Assay Market by Method: Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), and Others
  • 4.3: European Cystatin C Assay Market
    • 4.3.1: European Cystatin C Assay Market by Product: Analyzers, Kits, and Reagents
    • 4.3.2: European Cystatin C Assay Market by Method: Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), and Others
  • 4.4: APAC Cystatin C Assay Market
    • 4.4.1: APAC Cystatin C Assay Market by Product: Analyzers, Kits, and Reagents
    • 4.4.2: APAC Cystatin C Assay Market by Method: Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), and Others
  • 4.5: ROW Cystatin C Assay Market
    • 4.5.1: ROW Cystatin C Assay Market by Product: Analyzers, Kits, and Reagents
    • 4.5.2: ROW Cystatin C Assay Market by Method: Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cystatin C Assay Market by Product
    • 6.1.2: Growth Opportunities for the Global Cystatin C Assay Market by Sample Type
    • 6.1.3: Growth Opportunities for the Global Cystatin C Assay Market by Method
    • 6.1.4: Growth Opportunities for the Global Cystatin C Assay Market by Application
    • 6.1.5: Growth Opportunities for the Global Cystatin C Assay Market by Region
  • 6.2: Emerging Trends in the Global Cystatin C Assay Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cystatin C Assay Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cystatin C Assay Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Roche Diagnostics
  • 7.3: Siemens Healthcare
  • 7.4: Thermo Fisher Scientific
  • 7.5: Randox Laboratories